• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Healthcare

doctor-stethoscope
Norwest backs India hospital, HealthQuad marks 3x exit

Norwest Venture Partners has invested INR 4.5bn (USD 54m) in Indian hospital operator Regency Healthcare, facilitating an exit for HealthQuad, which generated a 3x return.

  • South Asia
  • 08 November 2023
xray-diagnostic-image-radiology-06
Five V backs Australia radioactive drug maker

Australia’s Five V Capital has confirmed an investment of undisclosed size in Cyclotek, a radioactive drug maker positioning itself as part of an industry transition toward personalized medicine.

  • Australasia
  • 06 November 2023
diabetes
MassMutual Ventures leads Series A for India's Sugarfit

Sugarfit, an India-based health technology start-up that helps people manage type-two diabetes with a view to reversing the condition, has raised USD 11m in Series A funding.

  • South Asia
  • 03 November 2023
biotech-lab-healthcare-pharma-02
Polaris leads $27m round for Singapore's Engine Biosciences

US healthcare and life sciences growth investor Polaris Partners has led a USD 27m Series A round for Singapore-based cancer medicine developer Engine Biosciences.

  • Southeast Asia
  • 01 November 2023
hospital-operation-surgery-healthcare-01
CVC buys majority stake in Philippines hospital business

CVC Capital Partners has acquired a 63.94% stake in Philippines-based hospital operator The Medical City (TMC) following the completion of a tender offer.

  • Southeast Asia
  • 30 October 2023
virus-healthcare-drug-pharma
OrbiMed raises $4.3b for global, Asia funds

Healthcare investor OrbiMed has raised USD 4.3bn for its latest set of global funds, including its fifth Asia-focused vehicle.

  • Fundraising
  • 26 October 2023
hospital-surgery-nurse
CBC hits second close on China life science real assets fund

Specialist healthcare investor CBC Group has reached a second close on its China-focused life science real assets fund with USD 875m in commitments.

  • Greater China
  • 24 October 2023
east-ventures
East targets $30m for Indonesia healthcare VC fund

East Ventures has launched a dedicated Indonesia healthcare innovation fund with a target of USD 30m.

  • Southeast Asia
  • 19 October 2023
healthcare-stethoscope-s
Quadria hits $500m first close on third healthcare fund

Singapore-based healthcare specialist Quadria Capital has reached a first close of USD 500m on its third flagship fund. The target is USD 800m.

  • Southeast Asia
  • 19 October 2023
vulcan-augmetics
Quest backs Vietnam robotic prosthetics start-up

Singapore’s Quest Ventures has confirmed an investment of undisclosed size in Vietnam-based robotic prosthetics start-up Vulcan Augmetics.

  • Southeast Asia
  • 17 October 2023
healthcare-lab-pharma-drug-biotech
China's Atom Bioscience raises $83m

Chinese inflammatory and metabolic disease drug developer Atom Bioscience has raised USD 83m in Series D funding led by local biotech specialist Kaitai Capital.

  • Greater China
  • 17 October 2023
veterinary-clinic-pet
BPEA EQT acquires Australia's VetPartners

BPEA EQT has agreed to acquire VetPartners, operator of Australia and New Zealand’s largest network of pet clinics and hospitals, from National Veterinary Associates (NVA).

  • Australasia
  • 12 October 2023
dentist-dental-dentures
Mubadala supports buyout of Korea's Osstem Implant

Mubadala Investment has invested in Osstem Implant, a Korean manufacturer of dental implants that was taken private by MBK Partners and UCK Partners (formerly Unison Capital Korea) earlier this year.

  • North Asia
  • 06 October 2023
telehealth-telemedicine-healthcare-technology-doctor
Japan's WiL joins $27m round for health platform Micin

Japan-US cross-border investor World Innovation Lab (WiL) has joined a JPY 4bn (USD 27.3m) Series C round for Tokyo-based telemedicine and health platform Micin.

  • North Asia
  • 06 October 2023
dollar-money-bills-notes-stack-01
LeapFrog eyes February close, claims significant progress on fundraise

Impact investor LeapFrog Investments expects to close its fourth flagship fund in February, with a source close to the situation adding that "a significant share" of the targeted USD 1bn has already been raised.

  • South Asia
  • 05 October 2023
insurance-health-policy
True North agrees $326m India health insurance exit

True North has agreed to sell about 20% of its stake in Indian insurance company Niva Bupa to its UK-based joint venture partner, Bupa, for approximately INR 27bn (USD 326m).

  • South Asia
  • 03 October 2023
biotech-lab-healthcare-pharma-02
L Catterton backs beauty industry biotech supplier

L Catterton has led a CNY 200m (USD 27m) Series B round for Trautec, a China-based biotech start-up that develops synthetic proteins used in beauty and healthcare products.

  • Central Asia
  • 29 September 2023
healthcare-medical-technology
China healthcare AI start-up Huimei gets $41m Series D

Eastern Bell Capital has led a Series D round of more than CNY 300m (USD 41m) for Huimei Cloud Technology, a China-based provider of artificial intelligence-enabled (AI) software that helps doctors make clinical decisions.

  • Greater China
  • 28 September 2023
vishal-bali
Deal focus: Riding the wave in India single-speciality hospitals

TPG Capital’s Asia Healthcare Holdings has tapped a rich vein for private equity in acquiring India’s only nephrology and urology hospital. Technological leadership will support expansion

  • South Asia
  • 27 September 2023
biotech-lab-drug-research-development
Matrix, HongShan back China's Qihan Biotech

Matrix Partners China and HongShan (formerly Sequioa Capital China) have joined a USD 16m pre-Series B round for Qihan Biotech, a genome editing player active in human and agricultural therapies.

  • Greater China
  • 26 September 2023
hospital-operation-surgery-healthcare-equipment
Indian regulator approves Blackstone's purchase of Care Hospitals

The Blackstone Group’s proposed acquisition of India-based hospital chain Care Hospitals from TPG’s The Rise Fund has won approval from the national competition regulator.

  • South Asia
  • 25 September 2023
biotech-lab-healthcare-drug
China's Lynk Pharmaceutical increases Series C to $44m

China-based drug developer Lynk Pharmaceuticals has closed a second tranche of Series C funding, taking the overall size of the round to CNY 322m (USD 44m).

  • Greater China
  • 25 September 2023
doctor-stethoscope
TPG healthcare platform acquires India hospital chain

Asia Healthcare Holdings (AHH), a platform backed by TPG Capital and GIC, has acquired a majority stake in India’s Asian Institute of Nephrology and Urology (AINU) for about USD 72.2m.

  • South Asia
  • 21 September 2023
doctor-xray-cancer-hospital
PE-backed Concord Healthcare pursues HK IPO

Concord Healthcare Group, an onshore subsidiary of US-listed Chinese healthcare business Concord Medical, has filed for an IPO in Hong Kong.

  • Greater China
  • 20 September 2023
1 2 3
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013